The researchers hoped to learn about possible differences in treatment preferences for lupus among members of different racial/ethnic patient groups, as well as demographic or clinical characteristics associated with such preferences.
The new SLICC classification rule is more clinically relevant, includes updates and more inclusive definitions of lupus-related variables, and improves upon the ACR classification criteria in several important ways.
To update the ACR guidelines for the management of lupus nephritis, a team of lupus experts from around the country collaborated with the ACR. The researchers utilized extensive literature searches and expert opinions to develop the updated guidelines.
The researchers hoped to learn about the relationship between type I interferon and premature heart disease risk among people with lupus.
A more detailed understanding of the reproductive behavior of women with lupus can help identify their needs in terms of caring for their disease and become educated about its possible effects, including those on reproduction.
The use of lupus biomarkers, such as those present in the blood or urine, to help predict and/or manage lupus nephritis over time could be very useful. The results of this study highlight the potential feasibility of using lupus biomarkers to differentiate between acute and chronic kidney disease activity-related changes.
The researchers hoped to learn about the long-term outcomes of bone mass density (BMD) in children newly diagnosed with lupus.
Having lupus is known to negatively affect specific aspects of work life. In general, the following are associated with work loss among people with lupus: lower levels of education, minority race/ethnicity, advanced age, longer disease duration, higher disease activity, and cognitive involvement.